arrow
P

Paul G. Kluetz

us food & drug administration (fda)
H指数:52
被引数:9,929

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials

美国食品药品监督管理局对一线晚期免疫肿瘤学肾细胞癌试验中根据缓解深度进行的总生存期合并分析

2025-08-010
OAAI
Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trials

构建电子健康记录数据以促进真实世界数据研究的可行性: ICAREdata方法应用于多中心癌症临床试验

CANCER
IF5.1
2024-08-282
OAAI
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Chemotherapy
2024-08-011
OAAI
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development
2023-12-121
PRE
The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data
2023-03-135
OAAI